{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:45:34Z","timestamp":1787024734060,"version":"build-2736575974"},"reference-count":101,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Cancer is the second leading cause of mortality globally and is characterized by a multifactorial\netiology. Drug resistance and multidrug resistance are the reasons for the failure of many\nanticancer drugs that are in clinical practice now. The current review is a complete review of\nbenzimidazole hybrids with different heterocyclic rings, which are potential anticancer agents. We\nreviewed around 70 research works of benzimidazole hybrids published in high-impact journals,\nalong with a short discussion of structural features responsible for its activity against various\ncancers. This review highlighted benzimidazole hybrids as targeted anticancer agents with effects\non multiple targets. Researchers working on targeted medications for cancer treatment will benefit\nfrom this review when designing new scaffolds with benzimidazole moieties.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115734064313626240912063644","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T01:15:29Z","timestamp":1727745329000},"page":"169-194","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Benzimidazole Conjugates as Multi-target Anticancer Agents - A Comprehensive Review"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2697-4594","authenticated-orcid":true,"given":"R.S.","family":"Remya","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, C.L. Baid Metha College of Pharmacy, Thoraipakkam, Chennai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Ramalakshmi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, C.L. Baid Metha College of Pharmacy, Thoraipakkam, Chennai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.G. Safiya","family":"Aaliya","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, C.L. Baid Metha College of Pharmacy, Thoraipakkam, Chennai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Blossom","family":"Concilia","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, C.L. Baid Metha College of Pharmacy, Thoraipakkam, Chennai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Fameetha","family":"Thasneem","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, C.L. Baid Metha College of Pharmacy, Thoraipakkam, Chennai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rohini","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, C.L. Baid Metha College of Pharmacy, Thoraipakkam, Chennai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Narmadha","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, C.L. Baid Metha College of Pharmacy, Thoraipakkam, Chennai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"980141","DOI":"10.3389\/fonc.2022.980141","volume":"12","author":"Margherita B.","year":"2022","unstructured":"Margherita B.; Multi-target directed ligands for the treatment of cancer. Front Oncol  2022,12,980141","journal-title":"Front Oncol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.apsb.2022.09.010","volume":"13","author":"Lee Y.T.","year":"2023","unstructured":"Lee Y.T.; Tan Y.J.; Oon C.E.; Benzimidazole and its derivatives as cancer therapeutics: The potential role from traditional to precision medicine. Acta Pharm Sin B  2023,13(2),478-497","journal-title":"Acta Pharm Sin B"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2174\/0115734064251256231018104623","volume":"20","author":"Kesavamoorthy K.","year":"2024","unstructured":"Kesavamoorthy K.; Surajambika R.R.; Velayudham K.P.; Pyrazolo-pyrimidines as targeted anticancer scaffolds: A comprehensive review. Med Chem  2024,20(3),293-310","journal-title":"Med Chem"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2200051","DOI":"10.1002\/ardp.202200051","volume":"355","author":"Feng L.S.","year":"2022","unstructured":"Feng L.S.; Su W.Q.; Cheng J.B.; Xiao T.; Li H.Z.; Chen D.A.; Zhang Z.L.; Benzimidazole hybrids as anticancer drugs: An updated review on anticancer properties, structure\u2013activity relationship, and mechanisms of action (2019\u20132021). Arch Pharm  2022,355(6),2200051","journal-title":"Arch Pharm"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"14586","DOI":"10.1021\/acsomega.0c01276","volume":"5","author":"Lee M.M.L.","year":"2020","unstructured":"Lee M.M.L.; Chan B.D.; Wong W.Y.; Leung T.W.; Qu Z.; Huang J.; Zhu L.; Lee C.S.; Chen S.; Tai W.C.S.; Synthesis and evaluation of novel anticancer compounds derived from the natural product brevilin A. ACS Omega  2020,5(24),14586-14596","journal-title":"ACS Omega"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"e040422203042","DOI":"10.2174\/1573407218666220404093136","volume":"18","author":"Palanikarasu P.","year":"2022","unstructured":"Palanikarasu P.; Surajambika R.R.; Ramalakshmi N.; Chalcones and flavones as multifunctional anticancer agents- A comprehensive review. Curr Bioact Compd  2022,18(10),e040422203042","journal-title":"Curr Bioact Compd"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"113921","DOI":"10.1016\/j.ejmech.2021.113921","volume":"227","year":"2022","unstructured":"G, A.C.; Gondru, R.; Li, Y.; Banothu, J. Coumarin\u2013benzimidazole hybrids: A review of developments in medicinal chemistry. Eur J Med Chem  2022,227,113921","journal-title":"Eur J Med Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"5436","DOI":"10.3390\/molecules27175436","volume":"27","author":"Ioele G.","year":"2022","unstructured":"Ioele G.; Chieffallo M.; Occhiuzzi M.A.; De Luca M.; Garofalo A.; Ragno G.; Grande F.; Anticancer drugs: Recent strategies to improve stability profile, pharmacokinetic and pharmacodynamic properties. Molecules  2022,27(17),5436","journal-title":"Molecules"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"111850","DOI":"10.1016\/j.ejmech.2019.111850","volume":"186","author":"Dokla E.M.E.","year":"2020","unstructured":"Dokla E.M.E.; Abutaleb N.S.; Milik S.N.; Li D.; El-Baz K.; Shalaby M.A.W.; Al-Karaki R.; Nasr M.; Klein C.D.; Abouzid K.A.M.; Seleem M.N.; Development of benzimidazole-based derivatives as antimicrobial agents and their synergistic effect with colistin against gram-negative bacteria. Eur J Med Chem  2020,186,111850","journal-title":"Eur J Med Chem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.3390\/antibiotics12071220","volume":"12","author":"Marinescu M.","year":"2023","unstructured":"Marinescu M.; Benzimidazole-triazole hybrids as antimicrobial and antiviral agents: A systematic review. Antibiotics  2023,12(7),1220","journal-title":"Antibiotics"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s13071-022-05347-y","volume":"15","author":"Valderas-Garc\u00eda E.","year":"2022","unstructured":"Valderas-Garc\u00eda E.; H\u00e4berli C.; \u00c1lvarez-Bard\u00f3n M.; Escala N.; Castilla-G\u00f3mez de Ag\u00fcero V.; de la Vega J.; del Olmo E.; Bala\u00f1a-Fouce R.; Keiser J.; Mart\u00ednez-Valladares M.; Benzimidazole and aminoalcohol derivatives show in vitro anthelmintic activity against Trichuris muris and Heligmosomoides polygyrus. Parasit Vectors  2022,15(1),243","journal-title":"Parasit Vectors"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00044-017-2036-1","volume":"27","author":"Sethi P.","year":"2018","unstructured":"Sethi P.; Bansal Y.; Bansal G.; Synthesis and PASS-assisted evaluation of coumarin\u2013benzimidazole derivatives as potential anti-inflammatory and anthelmintic agents. Med Chem Res  2018,27(1),61-71","journal-title":"Med Chem Res"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.3390\/molecules25071487","volume":"25","author":"Francesconi V.","year":"2020","unstructured":"Francesconi V.; Cichero E.; Schenone S.; Naesens L.; Tonelli M.; Synthesis and biological evaluation of novel (thio)semicarbazone-based benzimidazoles as antiviral agents against human respiratory viruses. Molecules  2020,25(7),1487","journal-title":"Molecules"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1002\/cbdv.200890203","volume":"5","author":"Tonelli M.","year":"2008","unstructured":"Tonelli M.; Paglietti G.; Boido V.; Sparatore F.; Marongiu F.; Marongiu E.; La Colla P.; Loddo R.; Antiviral activity of benzimidazole derivatives. I. Antiviral activity of 1-substituted-2-[(benzotriazol-1\/2-yl)methyl]benzimidazoles. Chem Biodivers  2008,5(11),2386-2401","journal-title":"Chem Biodivers"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"4369","DOI":"10.1021\/acsomega.2c07755","volume":"8","author":"G\u00fczel E.","year":"2023","unstructured":"G\u00fczel E.; Acar \u00c7evik U.; Evren A.E.; Bostanc\u0131 H.E.; G\u00fcl \u00dc.D.; Kay\u0131\u015f U.; \u00d6zkay Y.; Kaplanc\u0131kl\u0131 Z.A.; Synthesis of benzimidazole-1,2,4-triazole derivatives as potential antifungal agents targeting 14\u03b1-Demethylase. ACS Omega  2023,8(4),4369-4384","journal-title":"ACS Omega"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"103956","DOI":"10.1016\/j.bioorg.2020.103956","volume":"101","author":"Morcoss M.M.","year":"2020","unstructured":"Morcoss M.M.; Abdelhafez E.S.M.N.; Ibrahem R.A.; Abdel-Rahman H.M.; Abdel-Aziz M.; Abou El-Ella D.A.; Design, synthesis, mechanistic studies and in silico ADME predictions of benzimidazole derivatives as novel antifungal agents. Bioorg Chem  2020,101,103956","journal-title":"Bioorg Chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"135621","DOI":"10.1016\/j.molstruc.2023.135621","volume":"1286","author":"Mohamed M.S.","year":"2023","unstructured":"Mohamed M.S.; Ibrahim N.A.; Gouda A.M.; badr, M.; El-Sherief, H.A.M. Design, synthesis and molecular docking of 1,2,4-triazole schiff base hybrids as tubulin, EGFR inhibitors and apoptosis-inducers. J Mol Struct  2023,1286,135621","journal-title":"J Mol Struct"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/jhet.4355","volume":"59","author":"Satija G.","year":"2022","unstructured":"Satija G.; Sharma B.; Madan A.; Iqubal A.; Shaquiquzzaman M.; Akhter M.; Parvez S.; Khan M.A.; Alam M.M.; Benzimidazole based derivatives as anticancer agents: Structure activity relationship analysis for various targets. J Heterocycl Chem  2022,59(1),22-66","journal-title":"J Heterocycl Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1515\/chem-2021-0093","volume":"19","author":"Siddig L.A.","year":"2021","unstructured":"Siddig L.A.; Khasawneh M.A.; Samadi A.; Saadeh H.; Abutaha N.; Wadaan M.A.; Synthesis of novel thiourea-\/urea-benzimidazole derivatives as anticancer agents. Open Chem  2021,19(1),1062-1073","journal-title":"Open Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"104042","DOI":"10.1016\/j.bioorg.2020.104042","volume":"101","author":"Wu Z.","year":"2020","unstructured":"Wu Z.; Xia M.B.; Bertsetseg D.; Wang Y.H.; Bao X.L.; Zhu W.B.; Tao-Xu; Chen, P.R.; Tang, H.S.; Yan, Y.J.; Chen, Z.L. Design, synthesis and biological evaluation of novel fluoro-substituted benzimidazole derivatives with anti-hypertension activities. Bioorg Chem  2020,101,104042","journal-title":"Bioorg Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.21608\/ejchem.2021.79840.3931","volume":"64","author":"Sethy S.","year":"2021","unstructured":"Sethy S.; Mandal S.; Ewies E.; Dhiman N.; Garg A.; Synthesis, characterization and biological evaluation of benzimidazole and benzindazole derivatives as anti-hypertensive agents. Egypt J Chem  2021,64(7),3659-3684","journal-title":"Egypt J Chem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.bmcl.2009.11.122","volume":"20","author":"Cole D.C.","year":"2010","unstructured":"Cole D.C.; Gross J.L.; Comery T.A.; Aschmies S.; Hirst W.D.; Kelley C.; Kim J.I.; Kubek K.; Ning X.; Platt B.J.; Robichaud A.J.; Solvibile W.R.; Stock J.R.; Tawa G.; Williams M.J.; Ellingboe J.W.; Benzimidazole- and indole-substituted 1,3\u2032-bipyrrolidine benzamides as histamine H3 receptor antagonists. Bioorg Med Chem Lett  2010,20(3),1237-1240","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"5032","DOI":"10.1016\/j.bmcl.2008.08.008","volume":"18","author":"Aslanian R.","year":"2008","unstructured":"Aslanian R.; Zhu X.; Vaccaro H.A.; Shih N.Y.; Piwinski J.J.; Williams S.M.; West R.E.; Jr Benzimidazole-substituted (3-phenoxypropyl)amines as histamine H3 receptor ligands. Bioorg Med Chem Lett  2008,18(18),5032-5036","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"130029","DOI":"10.1016\/j.molstruc.2021.130029","volume":"1232","author":"Hussain S.","year":"2021","unstructured":"Hussain S.; Taha M.; Rahim F.; Hayat S.; Zaman K.; Iqbal N.; Selvaraj M.; Sajid M.; Bangesh M.A.; Khan F.; Khan K.M.; Uddin N.; Shah S.A.A.; Ali M.; Synthesis of benzimidazole derivatives as potent inhibitors for \u03b1-amylase and their molecular docking study in management of type-II diabetes. J Mol Struct  2021,1232,130029","journal-title":"J Mol Struct"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"12397","DOI":"10.1038\/s41598-023-39424-8","volume":"13","author":"Yousefnejad F.","year":"2023","unstructured":"Yousefnejad F.; Mohammadi-Moghadam-Goozali M.; Sayahi M.H.; Halimi M.; Moazzam A.; Mohammadi-Khanaposhtani M.; Mojtabavi S.; Asadi M.; Faramarzi M.A.; Larijani B.; Amanlou M.; Mahdavi M.; Design, synthesis, in vitro, and in silico evaluations of benzo[d]imidazole-amide-1,2,3-triazole-N-arylacetamide hybrids as new antidiabetic agents targeting \u03b1-glucosidase. Sci Rep  2023,13(1),12397","journal-title":"Sci Rep"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ejmech.2012.11.005","volume":"59","author":"Chen Q.","year":"2013","unstructured":"Chen Q.; Tian W.; Han G.; Qi J.; Zheng C.; Zhou Y.; Ding L.; Zhao J.; Zhu J.; Lv J.; Sheng C.; Design and synthesis of novel benzoheterocyclic derivatives as human acrosin inhibitors by scaffold hopping. Eur J Med Chem  2013,59,176-182","journal-title":"Eur J Med Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"107400","DOI":"10.1016\/j.compbiolchem.2020.107400","volume":"89","author":"Srivastava R.","year":"2020","unstructured":"Srivastava R.; Gupta S.K.; Naaz F.; Sen Gupta P.S.; Yadav M.; Singh V.K.; Singh A.; Rana M.K.; Gupta S.K.; Schols D.; Singh R.K.; Alkylated benzimidazoles: Design, synthesis, docking, DFT analysis, ADMET property, molecular dynamics and activity against HIV and YFV. Comput Biol Chem  2020,89,107400","journal-title":"Comput Biol Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3390\/ph13040068","volume":"13","author":"Baldisserotto A.","year":"2020","unstructured":"Baldisserotto A.; Demurtas M.; Lampronti I.; Tacchini M.; Moi D.; Balboni G.; Vertuani S.; Manfredini S.; Onnis V.; In-vitro evaluation of antioxidant, antiproliferative and photo-protective activities of benzimidazolehydrazone derivatives. Pharmaceuticals  2020,13(4),68","journal-title":"Pharmaceuticals"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"131027","DOI":"10.1016\/j.tet.2020.131027","volume":"76","author":"Zhang T.","year":"2020","unstructured":"Zhang T.; Liu Q.; Ren Y.; Design, synthesis and biological activity evaluation of novel methyl substituted benzimidazole derivatives. Tetrahedron  2020,76(13),131027","journal-title":"Tetrahedron"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"762807","DOI":"10.3389\/fphar.2021.762807","volume":"12","author":"Brishty S.R.","year":"2021","unstructured":"Brishty S.R.; Hossain M.J.; Khandaker M.U.; Faruque M.R.I.; Osman H.; Rahman S.M.A.; A comprehensive account on recent progress in pharmacological activities of benzimidazole derivatives. Front Pharmacol  2021,12,762807","journal-title":"Front Pharmacol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13045-020-00977-0","volume":"13","author":"Huang L.","year":"2020","unstructured":"Huang L.; Jiang S.; Shi Y.; Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001\u20132020). J Hematol Oncol  2020,13(1),143","journal-title":"J Hematol Oncol"},{"key":"ref=32","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.101702","author":"Haider K.","year":"2022","unstructured":"Haider K.; Shahar Yar M.;  Advances of Benzimidazole Derivatives as Anticancer Agents: Bench to Bedside; Benzimidazole  2022","journal-title":"Advances of Benzimidazole Derivatives as Anticancer Agents: Bench to Bedside; Benzimidazole"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.ejmech.2016.12.010","volume":"126","author":"Akhtar W.","year":"2017","unstructured":"Akhtar W.; Khan M.F.; Verma G.; Shaquiquzzaman M.; Rizvi M.A.; Mehdi S.H.; Akhter M.; Alam M.M.; Therapeutic evolution of benzimidazole derivatives in the last quinquennial period. Eur J Med Chem  2017,126,705-753","journal-title":"Eur J Med Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"174027","DOI":"10.1016\/j.ejphar.2021.174027","volume":"899","author":"Choudhary S.","year":"2021","unstructured":"Choudhary S.; Arora M.; Verma H.; Kumar M.; Silakari O.; Benzimidazole based hybrids against complex diseases: A catalogue of the SAR profile. Eur J Pharmacol  2021,899,174027","journal-title":"Eur J Pharmacol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"103576","DOI":"10.1016\/j.bioorg.2020.103576","volume":"96","author":"Rashid M.","year":"2020","unstructured":"Rashid M.; Design, synthesis and ADMET prediction of bis-benzimidazole as anticancer agent. Bioorg Chem  2020,96,103576","journal-title":"Bioorg Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1080\/14756360802694427","volume":"24","author":"Sharma D.","year":"2009","unstructured":"Sharma D.; Narasimhan B.; Kumar P.; Judge V.; Narang R.; De Clercq E.; Balzarini J.; Synthesis, antimicrobial and antiviral activity of substituted benzimidazoles. J Enzyme Inhib Med Chem  2009,24(5),1161-1168","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"109163","DOI":"10.1016\/j.cbi.2020.109163","volume":"327","author":"Atmaca H.","year":"2020","unstructured":"Atmaca H.; \u0130lhan S.; Bat\u0131r M.B.; Pulat \u00c7.\u00c7.; G\u00fcner A.; Bekta\u015f H.; Novel benzimidazole derivatives: Synthesis, in vitro cytotoxicity, apoptosis and cell cycle studies. Chem Biol Interact  2020,327,109163-3","journal-title":"Chem Biol Interact"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.3906\/kim-1904-46","volume":"43","author":"G\u00fcner A.","year":"2019","unstructured":"G\u00fcner A.; Polatli E.; Akkan T.; Bekta\u015f H.; Albay C.; Anticancer and antiangiogenesis activities of novel synthesized 2-substitutedbenzimidazoles molecules. Turk J Chem  2019,43(5),1270-1289","journal-title":"Turk J Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"e1686","DOI":"10.1038\/cddis.2015.25","volume":"6","author":"Chu B.","year":"2015","unstructured":"Chu B.; Liu F.; Li L.; Ding C.; Chen K.; Sun Q.; Shen Z.; Tan Y.; Tan C.; Jiang Y.; A benzimidazole derivative exhibiting antitumor activity blocks EGFR and HER2 activity and upregulates DR5 in breast cancer cells. Cell Death Dis  2015,6(3),e1686-e6","journal-title":"Cell Death Dis"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.ejmech.2008.07.013","volume":"44","author":"Galal S.A.","year":"2009","unstructured":"Galal S.A.; Hegab K.H.; Kassab A.S.; Rodriguez M.L.; Kerwin S.M.; El-Khamry A.M.A.; El Diwani H.I.; New transition metal ion complexes with benzimidazole-5-carboxylic acid hydrazides with antitumor activity. Eur J Med Chem  2009,44(4),1500-1508","journal-title":"Eur J Med Chem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"4419","DOI":"10.1016\/j.bmc.2007.04.032","volume":"15","author":"Star\u010devi\u0107 K.","year":"2007","unstructured":"Star\u010devi\u0107 K.; Kralj M.; Ester K.; Sabol I.; Grce M.; Synthesis, antiviral and antitumor activity of 2-substituted-5-amidino-benzimidazoles. Bioorg Med Chem  2007,15(13),4419-4426","journal-title":"Bioorg Med Chem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3390\/molecules17010873","volume":"17","author":"Xiang P.","year":"2012","unstructured":"Xiang P.; Zhou T.; Wang L.; Sun C.Y.; Hu J.; Zhao Y.L.; Yang L.; Novel benzothiazole, benzimidazole and benzoxazole derivatives as potential antitumor agents: synthesis and preliminary in vitro biological evaluation. Molecules  2012,17(1),873-883","journal-title":"Molecules"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"100556","DOI":"10.1016\/j.cdc.2020.100556","volume":"30","author":"Pragathi Y.J.","year":"2020","unstructured":"Pragathi Y.J.; Veronica D.; Anitha K.; Rao M.V.B.; Raju R.R.; Synthesis and biological evaluation of chalcone derivatives of 1,2,4-thiadiazol-benzo[d]imidazol-2-yl)quinolin-2(1H)-one as anticancer agents. Chem Data Collect  2020,30,100556","journal-title":"Chem Data Collect"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1248\/cpb.c17-00922","volume":"66","author":"Mohareb R.M.","year":"2018","unstructured":"Mohareb R.M.; Abdallah A.E.M.; Mohamed A.A.; Synthesis of novel thiophene, thiazole and coumarin derivatives based on benzimidazole nucleus and their cytotoxicity and toxicity evaluations. Chem Pharm Bull  2018,66(3),309-318","journal-title":"Chem Pharm Bull"},{"key":"ref=45","first-page":"465","volume":"73","author":"Yadav S.","year":"2018","unstructured":"Yadav S.; Narasimhan B.; Benzimidazole\u2013Schiff bases and their complexes: synthesis, anticancer activity and molecular modeling as Aurora kinase inhibitor. J Nat Sci C  2018,73(11-12),465-478","journal-title":"J Nat Sci C"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"108178","DOI":"10.1016\/j.carres.2020.108178","volume":"498","author":"Shinde V.S.","year":"2020","unstructured":"Shinde V.S.; Lawande P.P.; Sontakke V.A.; Khan A.; Synthesis of benzimidazole nucleosides and their anticancer activity. Carbohydr Res  2020,498,108178-8","journal-title":"Carbohydr Res"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1515\/znc-2018-0010","volume":"73","author":"Magd-El-Din A.A.","year":"2018","unstructured":"Magd-El-Din A.A.; Mousa H.A.; Labib A.A.; Hassan A.S.; Abd El-All A.S.; Ali M.M.; El-Rashedy A.A.; El-Desoky A.H.; Benzimidazole \u2013 Schiff bases and their complexes: Synthesis, anticancer activity and molecular modeling as Aurora kinase inhibitor. Z Naturforsch C J Biosci  2018,73(11-12),465-478","journal-title":"Z Naturforsch C J Biosci"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13065-019-0567-x","volume":"13","author":"Tahlan S.","year":"2019","unstructured":"Tahlan S.; Kumar S.; Ramasamy K.; Lim S.M.; Shah S.A.A.; Mani V.; Pathania R.; Narasimhan B.; Design, synthesis and biological profile of heterocyclic benzimidazole analogues as prospective antimicrobial and antiproliferative agents. BMC Chem  2019,13(1),50","journal-title":"BMC Chem"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ejmech.2017.11.037","volume":"144","author":"Cheong J.E.","year":"2018","unstructured":"Cheong J.E.; Zaffagni M.; Chung I.; Xu Y.; Wang Y.; Jernigan F.E.; Zetter B.R.; Sun L.; Synthesis and anticancer activity of novel water soluble benzimidazole carbamates. Eur J Med Chem  2018,144,372-385","journal-title":"Eur J Med Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.ejmech.2017.05.064","volume":"137","author":"El-Gohary N.S.","year":"2017","unstructured":"El-Gohary N.S.; Shaaban M.I.; Synthesis, antimicrobial, antiquorum-sensing and antitumor activities of new benzimidazole analogs. Eur J Med Chem  2017,137,439-449","journal-title":"Eur J Med Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1550018","DOI":"10.1142\/S0219633615500182","volume":"14","author":"Farmanzadeh D.","year":"2015","unstructured":"Farmanzadeh D.; Najafi M.; Benzimidazole derivatives as anticancer drugs: A theoretical investigation. J Theor Comput Chem  2015,14(3),1550018-8","journal-title":"J Theor Comput Chem"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jorganchem.2016.11.020","volume":"828","author":"Apohan E.","year":"2017","unstructured":"Apohan E.; Yilmaz U.; Yilmaz O.; Serinda\u011f A.; K\u00fc\u00e7\u00fckbay H.; Yesilada O.; Baran Y.; Synthesis, cytotoxic and antimicrobial activities of novel cobalt and zinc complexes of benzimidazole derivatives. J Organomet Chem  2017,828,52-58","journal-title":"J Organomet Chem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jorganchem.2017.03.037","volume":"839","author":"Akko\u00e7 S.","year":"2017","unstructured":"Akko\u00e7 S.; Kayser V.; \u0130lhan \u0130.\u00d6.; Hibbs D.E.; G\u00f6k Y.; Williams P.A.; Hawkins B.; Lai F.; New compounds based on a benzimidazole nucleus: Synthesis, characterization and cytotoxic activity against breast and colon cancer cell lines. J Organomet Chem  2017,839,98-107","journal-title":"J Organomet Chem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"E111023222069","DOI":"10.2174\/0115734072255749230928060834","volume":"19","author":"Remya R.S.","year":"2023","unstructured":"Remya R.S.; Barath R.; Ruban R.; Jaitharasan, V 2D QSAR modelling, docking, synthesis and evaluation of 2-substituted benzimidazole derivatives as anti-breast cancer agents. Curr Bioact Compd  2023,19(5),E111023222069","journal-title":"Curr Bioact Compd"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3184\/174751916X14577069096465","volume":"40","author":"Shaaban M.A-E.","year":"2016","unstructured":"Shaaban M.A-E.; Kamal A.M.; Teba H.E-S.; Synthesis, characterisation and biological screening of some 2-substituted benzimidazole derivatives as potential anticancer agents. J Chem Res  2016,40(4),228-234","journal-title":"J Chem Res"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1080\/10406638.2020.1833050","volume":"42","year":"2020","unstructured":"Magda, Synthesis and antitumor activity of novel hybrids of pyrimidine\/benzimidazole scaffolds. Polycycl Aromat Compd  2020,42(5),2363-2377","journal-title":"Polycycl Aromat Compd"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"104765","DOI":"10.1016\/j.bioorg.2021.104765","volume":"110","author":"Sana S.","year":"2021","unstructured":"Sana S.; Reddy V.G.; Srinivasa R.T.; Tokala R.; Kumar R.; Bhargava S.K.; Shankaraiah N.; Cinnamide derived pyrimidine-benzimidazole hybrids as tubulin inhibitors: Synthesis, in silico and cell growth inhibition studies. Bioorg Chem  2021,110,104765-5","journal-title":"Bioorg Chem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1002\/jhet.4052","volume":"57","author":"Haoran W.","year":"2020","unstructured":"Haoran W.; Akhtar W.; Nainwal L.M.; Kaushik S.K.; Akhter M.; Shaquiquzzaman M.; Alam M.M.; Synthesis and biological evaluation of benzimidazole pendant cyanopyrimidine derivatives as anticancer agents. J Heterocycl Chem  2020,57(9),3350-3360","journal-title":"J Heterocycl Chem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1016\/j.ejmech.2010.02.011","volume":"45","author":"Abdel-Mohsen H.T.","year":"2010","unstructured":"Abdel-Mohsen H.T.; Ragab F.A.F.; Ramla M.M.; El Diwani H.I.; Novel benzimidazole\u2013pyrimidine conjugates as potent antitumor agents. Eur J Med Chem  2010,45(6),2336-2344","journal-title":"Eur J Med Chem"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"103218","DOI":"10.1016\/j.bioorg.2019.103218","volume":"92","author":"Abdelgawad M.A.","year":"2019","unstructured":"Abdelgawad M.A.; Bakr R.B.; Ahmad W.; Al-Sanea M.M.; Elshemy H.A.H.; New pyrimidine-benzoxazole\/benzimidazole hybrids: Synthesis, antioxidant, cytotoxic activity, in vitro cyclooxygenase and phospholipase A2-V inhibition. Bioorg Chem  2019,92,103218","journal-title":"Bioorg Chem"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"s129","DOI":"10.5530\/ijper.53.2s.57","volume":"53","author":"Padhy G.K.","year":"2019","unstructured":"Padhy G.K.; Panda J.; Behera A.K.; Synthesis and characterization of novel n-benzylbenzimidazole linked pyrimidine derivatives as anticancer agents. Indian J Pharm Educ Res  2019,53(2s),s129-s134","journal-title":"Indian J Pharm Educ Res"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1016\/j.bmcl.2014.06.050","volume":"24","author":"Shao K.P.","year":"2014","unstructured":"Shao K.P.; Zhang X.Y.; Chen P.J.; Xue D.Q.; He P.; Ma L.Y.; Zheng J.X.; Zhang Q.R.; Liu H.M.; Synthesis and biological evaluation of novel pyrimidine\u2013benzimidazol hybrids as potential anticancer agents. Bioorg Med Chem Lett  2014,24(16),3877-3881","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.3390\/molecules25051162","volume":"25","author":"Wu L.","year":"2020","unstructured":"Wu L.; Yang Y.; Wang Z.; Wu X.; Su F.; Li M.; Jing X.; Han C.; Design, synthesis, and biological evaluation of aromatic amide-substituted benzimidazole-derived chalcones. The effect of upregulating TP53 protein expression. Molecules  2020,25(5),1162","journal-title":"Molecules"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.compbiolchem.2016.02.001","volume":"61","author":"Chhajed S.S.","year":"2016","unstructured":"Chhajed S.S.; Sonawane S.S.; Upasani C.D.; Kshirsagar S.J.; Gupta P.P.; Design, synthesis and molecular modeling studies of few chalcone analogues of benzimidazole for epidermal growth factor receptor inhibitor in search of useful anticancer agent. Comput Biol Chem  2016,61,138-144","journal-title":"Comput Biol Chem"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"20381","DOI":"10.1021\/acsomega.9b03077","volume":"4","author":"Yang J.L.","year":"2019","unstructured":"Yang J.L.; Ma Y.H.; Li Y.H.; Zhang Y.P.; Tian H.C.; Huang Y.C.; Li Y.; Chen W.; Yang L.J.; Design, synthesis, and anticancer activity of novel trimethoxyphenyl-derived chalcone-benzimidazolium salts. ACS Omega  2019,4(23),20381-20393","journal-title":"ACS Omega"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.3390\/molecules25143180","volume":"25","author":"Zhou W.","year":"2020","unstructured":"Zhou W.; Zhang W.; Peng Y.; Jiang Z.H.; Zhang L.; Du Z.; Design, synthesis and anti-tumor activity of novel benzimidazole-chalcone hybrids as non-intercalative topoisomerase II catalytic inhibitors. Molecules  2020,25(14),3180","journal-title":"Molecules"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.3390\/molecules24183259","volume":"24","author":"Hsieh C.Y.","year":"2019","unstructured":"Hsieh C.Y.; Ko P.W.; Chang Y.J.; Kapoor M.; Liang Y.C.; Chu H-L.; Lin H-H.; Horng J-C.; Hsu M-H.; Design and synthesis of benzimidazole-chalcone derivatives as potential anticancer agents. Molecules  2019,24(18),3259","journal-title":"Molecules"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s12039-019-1647-0","volume":"131","author":"Karata\u015f M.O.","year":"2019","unstructured":"Karata\u015f M.O.; Tekin S.; Alici B.; Sandal S.; Cytotoxic effects of coumarin substituted benzimidazolium salts against human prostate and ovarian cancer cells. J Chem Sci  2019,131(8),69","journal-title":"J Chem Sci"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jinorgbio.2018.02.012","volume":"183","author":"Gautam A.C.R.","year":"2018","unstructured":"Gautam A.C.R.; Sterically modulated silver(I) complexes of coumarin substituted benzimidazol-2-ylidenes: Synthesis, crystal structures and evaluation of their antimicrobial and antilung cancer potentials. J Inorg Biochem  2018,183,43-57","journal-title":"J Inorg Biochem"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"4638","DOI":"10.1002\/slct.201600665","volume":"1","author":"Holiyachi M.","year":"2016","unstructured":"Holiyachi M.; Shastri S.L.; Chougala B.M.; Shastri L.A.; Joshi S.D.; Dixit S.R.; Nagarajaiah H.; Sunagar V.A.; Design, synthesis and structure\u2010activity relationship study of coumarin benzimidazole hybrid as potent antibacterial and anticancer agents. ChemistrySelect  2016,1(15),4638-4644","journal-title":"ChemistrySelect"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1097\/CAD.0000000000000232","volume":"26","author":"Liu H.","year":"2015","unstructured":"Liu H.; Wang Y.; Sharma A.; Mao R.; Jiang N.; Dun B.; She J.X.; Derivatives containing both coumarin and benzimidazole potently induce caspase-dependent apoptosis of cancer cells through inhibition of PI3K-AKT-mTOR signaling. Anticancer Drugs  2015,26(6),667-677","journal-title":"Anticancer Drugs"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1016\/j.bmcl.2012.12.071","volume":"23","author":"Paul K.","year":"2013","unstructured":"Paul K.; Bindal S.; Luxami V.; Synthesis of new conjugated coumarin\u2013benzimidazole hybrids and their anticancer activity. Bioorg Med Chem Lett  2013,23(12),3667-3672","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"2166037","DOI":"10.1080\/14756366.2023.2166037","volume":"38","author":"Othman D.I.A.","year":"2023","unstructured":"Othman D.I.A.; Hamdi A.; Tawfik S.S.; Elgazar A.A.; Mostafa A.S.; Identification of new benzimidazole-triazole hybrids as anticancer agents: Multi-target recognition, in vitro and in silico studies. J Enzyme Inhib Med Chem  2023,38(1),2166037","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"104","DOI":"10.25303\/2511rjce104109","volume":"25","author":"Kumaraswamy G.","year":"2021","unstructured":"Kumaraswamy G.; Maroju R.; Bandari S.; Dasari G.; Sadanandam G.; Design and synthesis of novel benzimidazoles containing 1,2,3-triazolesas in vitro, anticancer and anti-oxidant agents. Res J Chem Environ  2021,25(11),104-109","journal-title":"Res J Chem Environ"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1039\/D0MD00414F","volume":"12","author":"Singu P.S.","year":"2021","unstructured":"Singu P.S.; Benzimidazole-1,2,3-triazole hybrid molecules: Synthesis and study of their interaction with G-quadruplex DNA. RSC Med Chem  2021,12(3),416-429","journal-title":"RSC Med Chem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"104125","DOI":"10.1016\/j.bioorg.2020.104125","volume":"102","author":"Sridhar G.N.","year":"2020","unstructured":"Sridhar G.N.; Pooladanda V.; Muni C.K.; Lakshmi S.P.S.; Alvala R.; Kumar P.; Nagaraj C.; Dawn B.R.; Qureshi I.A.; Godugu C.; Alvala M.; Novel benzimidazole-triazole hybrids as apoptosis inducing agents in lung cancer: Design, synthesis, 18F-radiolabeling and galectin-1 inhibition studies. Bioorg Chem  2020,102,104125-5","journal-title":"Bioorg Chem"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.ejmech.2017.10.061","volume":"143","author":"Bistrovi\u0107 A.","year":"2018","unstructured":"Bistrovi\u0107 A.; Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer. Eur J Med Chem  2018,143,1616-1634","journal-title":"Eur J Med Chem"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1080\/00397911.2017.1289412","volume":"47","author":"Sahay I.I.","year":"2017","unstructured":"Sahay I.I.; Ghalsasi P.S.; Synthesis of new 1,2,3-triazole linked benzimidazole molecules as anti-proliferative agents. Synth Commun  2017,47(8),825-834","journal-title":"Synth Commun"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13588-014-0014-x","volume":"4","author":"Harkala K.J.","year":"2014","unstructured":"Harkala K.J.; Eppakayala L.; Maringanti T.C.; Synthesis and biological evaluation of benzimidazole-linked 1,2,3-triazole congeners as agents. Org Med Chem Lett  2014,4(1),14","journal-title":"Org Med Chem Lett"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1080\/14756366.2020.1806831","volume":"35","author":"Acar \u00c7evik U.","year":"2020","unstructured":"Acar \u00c7evik U.; Sa\u011fl\u0131k B.N.; Osmaniye D.; Levent S.; Kaya \u00c7avu\u015fo\u011flu B.; Karaduman A.B.; Atl\u0131 Eklio\u011flu \u00d6.; \u00d6zkay Y.; Kaplanc\u0131kl\u0131 Z.A.; Synthesis, anticancer evaluation and molecular docking studies of new benzimidazole- 1,3,4-oxadiazole derivatives as human topoisomerase types I poison. J Enzyme Inhib Med Chem  2020,35(1),1657-1673","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.ejmech.2016.12.014","volume":"126","author":"Akhtar M.J.","year":"2017","unstructured":"Akhtar M.J.; Siddiqui A.A.; Khan A.A.; Ali Z.; Dewangan R.P.; Pasha S.; Yar M.S.; Design, synthesis, docking and QSAR study of substituted benzimidazole linked oxadiazole as cytotoxic agents, EGFR and erbB2 receptor inhibitors. Eur J Med Chem  2017,126,853-869","journal-title":"Eur J Med Chem"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1016\/j.arabjc.2015.08.019","volume":"12","author":"Rashid M.","year":"2019","unstructured":"Rashid M.; Husain A.; Mishra R.; Karim S.; Khan S.; Ahmad M.; Al-wabel N.; Husain A.; Ahmad A.; Khan S.A.; Design and synthesis of benzimidazoles containing substituted oxadiazole, thiadiazole and triazolo-thiadiazines as a source of new anticancer agents. Arab J Chem  2019,12(8),3202-3224","journal-title":"Arab J Chem"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/jccs.202000130","volume":"68","author":"Husain A.","year":"2021","unstructured":"Husain A.; Bhutani M.; Parveen S.; Khan S.A.; Ahmad A.; Iqbal M.A.; Synthesis, in vitro cytotoxicity, ADME, and molecular docking studies of benzimidazole\u2010bearing furanone derivatives. J Chin Chem Soc (Taipei)  2021,68(2),362-373","journal-title":"J Chin Chem Soc (Taipei)"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"114369","DOI":"10.1016\/j.poly.2020.114369","volume":"179","author":"Li S.","year":"2020","unstructured":"Li S.; Zhao J.; Yuan B.; Wang X.; Zhang J.; Yue L.; Hou H.; Hu J.; Chen S.; Crystal structure, DNA interaction and in vitro anticancer activity of Cu(II) and Pt(II) compounds based on benzimidazole-quinoline derivative. Polyhedron  2020,179,114369-9","journal-title":"Polyhedron"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.procbio.2021.01.009","volume":"102","author":"Song W.","year":"2021","unstructured":"Song W.; Xu P.; Zhi S.; Zhu S.; Guo Y.; Yang H.; Integrated transcriptome and in vitro analysis revealed antiproliferative effects on human gastric cancer cells by a benzimidazole-quinoline copper(II) complex. Process Biochem  2021,102,286-295","journal-title":"Process Biochem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.bioorg.2018.02.005","volume":"77","author":"Baig M.F.","year":"2018","unstructured":"Baig M.F.; Nayak V.L.; Budaganaboyina P.; Mullagiri K.; Sunkari S.; Gour J.; Kamal A.; Synthesis and biological evaluation of imidazo[2,1-b]thiazole-benzimidazole conjugates as microtubule-targeting agents. Bioorg Chem  2018,77,515-526","journal-title":"Bioorg Chem"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1007\/s11094-020-02119-9","volume":"53","author":"\u00d6zdemir A.","year":"2020","unstructured":"\u00d6zdemir A.; Turanli S.; \u00c7ali\u015fkan B.; Arka M.; Banoglu E.; Evaluation of cytotoxic activity of new benzimidazole-piperazine hybrids against human MCF-7 and A549 cancer cells. Pharm Chem J  2020,53(11),1036-1046","journal-title":"Pharm Chem J"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"103929","DOI":"10.1016\/j.bioorg.2020.103929","volume":"100","author":"Karadayi F.Z.","year":"2020","unstructured":"Karadayi F.Z.; Yaman M.; Kisla M.M.; Keskus A.G.; Konu O.; Ates-Alagoz Z.; Design, synthesis and anticancer\/antiestrogenic activities of novel indole-benzimidazoles. Bioorg Chem  2020,100,103929-9","journal-title":"Bioorg Chem"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.bioorg.2018.03.002","volume":"78","author":"Akhtar M.J.","year":"2018","unstructured":"Akhtar M.J.; Khan A.A.; Ali Z.; Dewangan R.P.; Rafi M.; Hassan M.Q.; Akhtar M.S.; Siddiqui A.A.; Partap S.; Pasha S.; Yar M.S.; Synthesis of stable benzimidazole derivatives bearing pyrazole as anticancer and EGFR receptor inhibitors. Bioorg Chem  2018,78,158-169","journal-title":"Bioorg Chem"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.bioorg.2017.07.007","volume":"74","author":"Abdelgawad M.A.","year":"2017","unstructured":"Abdelgawad M.A.; Bakr R.B.; Omar H.A.; Design, synthesis and biological evaluation of some novel benzothiazole\/benzoxazole and\/or benzimidazole derivatives incorporating a pyrazole scaffold as antiproliferative agents. Bioorg Chem  2017,74,82-90","journal-title":"Bioorg Chem"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"e130821195659","DOI":"10.2174\/1573407217666210813144009","volume":"18","author":"Remya R.S.","year":"2022","unstructured":"Remya R.S.; Design, synthesis and pharmacological evaluation of novel benzimidazole derivatives as anticancer agents. Curr Bioact Compd  2022,18(6),e130821195659","journal-title":"Curr Bioact Compd"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.3390\/ph16121648","volume":"16","author":"Adardour M.","year":"2023","unstructured":"Adardour M.; Ait Lahcen M.; Oubahmane M.; Ettahiri W.; Hdoufane I.; Bouamama H.; Alanazi M.M.; Cherqaoui D.; Taleb M.; Garcia E.Z.; Baouid A.; Design, synthesis, molecular modeling and biological evaluation of novel pyrazole benzimidazolone derivatives as potent antioxidants. Pharmaceuticals  2023,16(12),1648","journal-title":"Pharmaceuticals"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.ejmech.2017.06.035","volume":"138","author":"Sharma P.","year":"2017","unstructured":"Sharma P.; Reddy T.S.; Kumar N.P.; Senwar K.R.; Bhargava S.K.; Shankaraiah N.; Conventional and microwave-assisted synthesis of new 1 H -benzimidazole-thiazolidinedione derivatives: A potential anticancer scaffold. Eur J Med Chem  2017,138,234-245","journal-title":"Eur J Med Chem"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0223-5234(01)01313-7","volume":"37","author":"Demirayak \u015e.","year":"2002","unstructured":"Demirayak \u015e.; Abu Mohsen U.; \u00c7a\u011fri K.A.; Synthesis and anticancer and anti-HIV testing of some pyrazino[1,2-a]benzimidazole derivatives. Eur J Med Chem  2002,37(3),255-260","journal-title":"Eur J Med Chem"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3109\/14756366.2013.858142","volume":"29","author":"Demirayak \u015e.","year":"2014","unstructured":"Demirayak \u015e.; Yurtta\u015f L.; Synthesis and anticancer activity of some 1,2,3-trisubstituted pyrazinobenzimidazole derivatives. J Enzyme Inhib Med Chem  2014,29(6),811-822","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.1039\/C4NJ02415J","volume":"39","author":"Sontakke V.A.","year":"2015","unstructured":"Sontakke V.A.; Kate A.N.; Ghosh S.; More P.; Gonnade R.; Kumbhar N.M.; Kumbhar A.A.; Chopade B.A.; Shinde V.S.; Synthesis, DNA interaction and anticancer activity of 2-anthryl substituted benzimidazole derivatives. New J Chem  2015,39(6),4882-4890","journal-title":"New J Chem"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1016\/j.bmc.2018.06.010","volume":"26","author":"He L.J.","year":"2018","unstructured":"He L.J.; Yang D.L.; Li S.Q.; Zhang Y.J.; Tang Y.; Lei J.; Frett B.; Lin H.; Li H.; Chen Z.Z.; Xu Z.G.; Facile construction of fused benzimidazole-isoquinolinones that induce cell-cycle arrest and apoptosis in colorectal cancer cells. Bioorg Med Chem  2018,26(14),3899-3908","journal-title":"Bioorg Med Chem"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1016\/j.bmcl.2013.03.107","volume":"23","author":"Sharma A.","year":"2013","unstructured":"Sharma A.; Luxami V.; Paul K.; Synthesis, single crystal and antitumor activities of benzimidazole\u2013quinazoline hybrids. Bioorg Med Chem Lett  2013,23(11),3288-3294","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13065-023-01003-3","volume":"17","author":"Hagar F.F.","year":"2023","unstructured":"Hagar F.F.; Abbas S.H.; Gomaa H.A.M.; Youssif B.G.M.; Sayed A.M.; Abdelhamid D.; Abdel-Aziz M.; Chalcone\/1,3,4-Oxadiazole\/Benzimidazole hybrids as novel anti-proliferative agents inducing apoptosis and inhibiting EGFR and BRAFV600E. BMC Chem  2023,17(1),116","journal-title":"BMC Chem"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s11030-018-9833-4","volume":"22","author":"Rao Y.J.","year":"2018","unstructured":"Rao Y.J.; Sowjanya T.; Thirupathi G.; Murthy N.Y.S.; Kotapalli S.S.; Synthesis and biological evaluation of novel flavone\/triazole\/benzimidazole hybrids and flavone\/isoxazole-annulated heterocycles as antiproliferative and antimycobacterial agents. Mol Divers  2018,22(4),803-814","journal-title":"Mol Divers"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"127487","DOI":"10.1016\/j.molstruc.2019.127487","volume":"1204","author":"Djemoui A.","year":"2020","unstructured":"Djemoui A.; Naouri A.; Ouahrani M.R.; Djemoui D.; Lahcene S.; Lahrech M.B.; Boukenna L.; Albuquerque H.M.T.; Saher L.; Rocha D.H.A.; Monteiro F.L.; Helguero L.A.; Bachari K.; Talhi O.; Silva A.M.S.; A step-by-step synthesis of triazole-benzimidazole-chalcone hybrids: Anticancer activity in human cells+. J Mol Struct  2020,1204,127487-7","journal-title":"J Mol Struct"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734064313626240912063644","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/234597\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734064313626240912063644","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T01:06:23Z","timestamp":1742173583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/234597\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":101,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115734064313626240912063644","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-04-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}